{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Choice+given&page=36", "query": { "intervention": "Choice given", "page": 36 }, "page_size": 10 }, "pagination": { "page": 36, "page_size": 10, "total_count": 903, "total_pages": 91, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Choice+given&page=37&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Choice+given&page=35&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-29T01:24:02.774Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03628820", "title": "Canine Assisted Therapy to Reduce Emergency Care Provider Stress", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Stress", "Anxiety" ], "interventions": [ { "name": "Dog Therapy", "type": "BEHAVIORAL" }, { "name": "Coloring", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Indiana University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 119, "start_date": "2018-05-17", "completion_date": "2019-08-09", "has_results": false, "last_update_posted_date": "2020-02-17", "last_synced_at": "2026-10-29T01:24:02.774Z", "location_count": 1, "location_summary": "Indianapolis, Indiana", "locations": [ { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT03628820" }, { "nct_id": "NCT02531997", "title": "A Mind-body Intervention to Improve Body and/or Self Image", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Breast Cancer", "Ovarian Cancer", "Uterine Cancer", "Cervical Cancer" ], "interventions": [ { "name": "Hypnotic Relaxation Therapy", "type": "BEHAVIORAL" }, { "name": "Progressive Muscle Relaxation", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Michigan", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "FEMALE", "summary": "21 Years and older · Female only" }, "enrollment_count": 97, "start_date": "2015-08", "completion_date": "2017-12", "has_results": false, "last_update_posted_date": "2017-12-12", "last_synced_at": "2026-10-29T01:24:02.774Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT02531997" }, { "nct_id": "NCT04370509", "title": "Pembrolizumab With or Without Axitinib for Clear Cell Kidney Cancer in Patients Undergoing Surgery", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Metastatic Clear Cell Renal Cell Carcinoma", "Recurrent Clear Cell Renal Cell Carcinoma", "Stage III Renal Cell Cancer AJCC v8", "Stage IV Renal Cell Cancer AJCC v8", "Clear Cell Renal Cell Carcinoma" ], "interventions": [ { "name": "Axitinib (VEGF-TKI)", "type": "DRUG" }, { "name": "Cytoreductive Nephrectomy (CN)", "type": "PROCEDURE" }, { "name": "Metastasectomy (MET)", "type": "PROCEDURE" }, { "name": "Pembrolizumab", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "PROCEDURE", "BIOLOGICAL" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 6, "start_date": "2021-02-09", "completion_date": "2025-02-28", "has_results": true, "last_update_posted_date": "2025-11-19", "last_synced_at": "2026-10-29T01:24:02.774Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04370509" }, { "nct_id": "NCT02785003", "title": "Ketamine in Colorectal Surgery", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Acute Pain", "Pain, Postoperative", "Colorectal Surgery" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Ketamine", "type": "DRUG" }, { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Opioid", "type": "DRUG" }, { "name": "Alvimopan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Medical College of Wisconsin", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2016-07", "completion_date": "2018-08", "has_results": false, "last_update_posted_date": "2017-10-26", "last_synced_at": "2026-10-29T01:24:02.774Z", "location_count": 1, "location_summary": "Milwaukee, Wisconsin", "locations": [ { "city": "Milwaukee", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT02785003" }, { "nct_id": "NCT02561273", "title": "Combination Chemotherapy & Lenalidomide in Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Anaplastic Large Cell Lymphoma, ALK-Negative", "Anaplastic Large Cell Lymphoma, ALK-Positive", "Hepatosplenic T-Cell Lymphoma", "Peripheral T-Cell Lymphoma, Not Otherwise Specified", "Stage II Angioimmunoblastic T-cell Lymphoma", "Stage II Enteropathy-Associated T-Cell Lymphoma", "Stage III Angioimmunoblastic T-cell Lymphoma", "Stage III Enteropathy-Associated T-Cell Lymphoma", "Stage IV Angioimmunoblastic T-cell Lymphoma", "Stage IV Enteropathy-Associated T-Cell Lymphoma" ], "interventions": [ { "name": "Autologous Hematopoietic Stem Cell Transplantation", "type": "PROCEDURE" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Doxorubicin Hydrochloride", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "Lenalidomide", "type": "DRUG" }, { "name": "Peripheral Blood Stem Cell Transplantation", "type": "PROCEDURE" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Vincristine Sulfate", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG", "OTHER" ], "sponsor": "University of Nebraska", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 54, "start_date": "2015-09-28", "completion_date": "2020-11-01", "has_results": true, "last_update_posted_date": "2023-12-13", "last_synced_at": "2026-10-29T01:24:02.774Z", "location_count": 8, "location_summary": "Duarte, California • Palo Alto, California • Aurora, Colorado + 5 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT02561273" }, { "nct_id": "NCT06780670", "title": "Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "Investigators choice of SoC", "type": "DRUG" }, { "name": "AAA817", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "MALE", "summary": "18 Years to 100 Years · Male only" }, "enrollment_count": 443, "start_date": "2025-02-27", "completion_date": "2033-07-19", "has_results": false, "last_update_posted_date": "2026-09-22", "last_synced_at": "2026-10-29T01:24:02.774Z", "location_count": 35, "location_summary": "Scottsdale, Arizona • Los Angeles, California • Palo Alto, California + 30 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Santa Barbara", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06780670" }, { "nct_id": "NCT01617122", "title": "Evaluate Bacteriophage as a Useful Immunogen in Patients With Primary Immune Deficiency Diseases (PIDD)", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Primary Immune Deficiency Diseases" ], "interventions": [ { "name": "Bacteriophage OX174", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "University of South Florida", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "2 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "2 Years to 85 Years" }, "enrollment_count": 200, "start_date": "1995-10", "completion_date": "2015-12", "has_results": false, "last_update_posted_date": "2012-07-17", "last_synced_at": "2026-10-29T01:24:02.774Z", "location_count": 1, "location_summary": "St. Petersburg, Florida", "locations": [ { "city": "St. Petersburg", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01617122" }, { "nct_id": "NCT04173572", "title": "Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance Life Randomized Control Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Schizophrenia", "Schizoaffective Disorder", "Brief Psychotic Disorder", "Schizophreniform Disorders", "Unspecified Schizophrenia Spectrum and Other Psychotic Disorder" ], "interventions": [ { "name": "PACE-Life", "type": "BEHAVIORAL" }, { "name": "Exercise Intervention", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 50, "start_date": "2019-12-20", "completion_date": "2022-03-23", "has_results": true, "last_update_posted_date": "2022-09-22", "last_synced_at": "2026-10-29T01:24:02.774Z", "location_count": 2, "location_summary": "Chapel Hill, North Carolina • Raleigh, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" }, { "city": "Raleigh", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT04173572" }, { "nct_id": "NCT06910670", "title": "Implementing a Randomized Control Trial to Test the Expanded Web-based Decision Aid", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cholangiocarcinoma", "Colorectal Cancer", "Multiple Myeloma" ], "interventions": [ { "name": "Standard developed materials", "type": "OTHER" }, { "name": "Genetics Advisor Decision Aid", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 197, "start_date": "2025-04-03", "completion_date": "2026-11-01", "has_results": false, "last_update_posted_date": "2026-09-25", "last_synced_at": "2026-10-29T01:24:02.774Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT06910670" }, { "nct_id": "NCT05251714", "title": "CFI-402257, a Potent and Selective TTK Inhibitor, in Solid Tumors and With Fulvestrant in Breast Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Advanced Solid Tumor", "Breast Cancer" ], "interventions": [ { "name": "CFI-402257", "type": "DRUG" }, { "name": "Fulvestrant", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Treadwell Therapeutics, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 44, "start_date": "2022-05-27", "completion_date": "2026-08", "has_results": false, "last_update_posted_date": "2025-05-18", "last_synced_at": "2026-10-29T01:24:02.774Z", "location_count": 4, "location_summary": "Columbus, Ohio • San Antonio, Texas • West Valley City, Utah + 1 more", "locations": [ { "city": "Columbus", "state": "Ohio" }, { "city": "San Antonio", "state": "Texas" }, { "city": "West Valley City", "state": "Utah" }, { "city": "Fairfax", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05251714" } ] }